Cite
HARVARD Citation
Desai, S. et al. (2023). Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma. American journal of hematology. 98 (3), pp. 464-471. [Online].